Open AccessAMN107, A Designed Bcr-Abl Inhibitor Effective in Gleevec-Resistant CML
Publication year - 2005
Publication title -
cancer biology and therapy
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 1.166
H-Index - 113
eISSN - 1555-8576
pISSN - 1538-4047
DOI - 10.4161/cbt.4.3.1625
Subject(s) - chronic myelogenous leukemia , imatinib , medicine , imatinib mesylate , tyrosine kinase , tyrosine kinase inhibitor , abl , nilotinib , pharmacology , cancer research , cancer , leukemia , receptor , myeloid leukemia
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom